why choose us

300×250 Ad Slot

Research Article: Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States

Date Published: 2023-07-24

Introduction:
Chronic obstructive pulmonary disease (COPD) is a progressive, incurable disease that can have a substantial impact on quality of life and reduce life expectancy. – Options for pharmacological therapy of COPD include bronchodilators (eg long-acting ? -agonists [LABA]), antimuscarinic drugs (eg long-acting muscarinic antagonists [LAMA]), methylxanthines, and anti-inflammatory agents (eg inhaled corticosteroids [ICS]). The Global Initiative for Chronic Obstructive Lung Disease (GOLD) clinical management guidelines…

Read more

300×250 Ad Slot